Dr. David A. Wink has had a long interest in the chemical aspects of Nitric oxide and related redox chemistry and their role in cancer and other diseases. He graduated with a Ph.D. in inorganic chemistry from University of California Santa Barbara in 1985. Then went on to do an NIH fellowship award at the Massechussetts Institute of Technology. He has been at the National Cancer Institute (NCI) since 1989 first in the division of Etiology then later in 1995 transferring to the Division of Clinical Sciences. In 2005, Dr. Wink founded and is chair of the Cancer Redox Biology Faculty in the Center for cancer research, NCI. Dr. Wink laboratory has investigated the role NO and other reactive chemical species have on different, toxicological, genotoxic and pathophysiological mechanisms from carcinogenesis to cancer treatment. These mechanisms have focused on chemical toxicology and there implication to carcinogenesis as well as cancer treatment. He is a fellow of the American Association for Science and has published over 230 papers as well as currently serves on the editorial boards of Free radical in Biology and Medicine, Nitric Oxide Chemistry and Biology and the Journal of Biological Chemistry.